# US 2014/0193371 A1 · Method for the Prevention and Treatment of Cancer, Tuberculosis and Related Diseases > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2014/0193371 A1 - Document ID: US20140193371A1 - Status: Published application - Kind: A1 - Application number: 14/149,180 - Filed: 2014-01-07 - Published: 2014-07-10 - Earliest claimed: 2013-01-07 - Inventors: Harold Edward Siess - Web page: https://patentgrep.com/patent/US20140193371A1 ## CPC - A61K 33/18: Iodine; Compounds thereof - A23L 33/30: {Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence)} - A61K 31/00: Medicinal preparations containing organic active ingredients - A61K 33/24: Heavy metals; Compounds thereof - A61K 33/34: Copper; Compounds thereof - A61K 33/36: Arsenic; Compounds thereof - A61K 33/38: Silver; Compounds thereof - A61K 35/74: Bacteria (therapeutic use of a bacterial protein A61K38/00) - A61K 35/76: Viruses; Subviral particles; Bacteriophages - A61K 38/164: {from bacteria} - A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca - A61K 33/241: Lead; Compounds thereof - A61K 33/242: Gold; Compounds thereof - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) - A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B) ## Abstract A method for preventing and treating one or more disease states including the steps of altering the diet of an individual and then administering a drug to the individual. Plasma vitamin C level is reduced from a first level to a second level that is lower than the first level, such that a pharmacological response of the body of the individual to a drug at the first level is different from the pharmacological response of the body of said individual to the drug at the second level. ## Claims ### Claim 1 A method for preventing and treating one or more disease states, the method comprising the steps of: a) altering a diet of an individual having a plasma vitamin C level in order to reduce the plasma vitamin C level from a first level to a second level that is lower than the first level, wherein a pharmacological response of the body of said individual to a drug at the first level is different from the pharmacological response of the body of said individual to the drug at the second level; and b) administering said drug to said individual. ### Claim 2 (depends on 1) The method according to claim 1 further comprising the step of measuring the plasma vitamin C level of said individual prior to administering the drug. ### Claim 3 (depends on 1) The method according to claim 1, wherein the plasma vitamin C level is maintained at the second level for at least one month. ### Claim 4 (depends on 1) The method according to claim 1 further comprising the step of administering an anti-vitamin C substance to the individual prior to administering the drug to reduce the plasma vitamin C level from the second level to a third level that is lower than the first or second levels. ### Claim 5 (depends on 4) The method according to claim 4, wherein administering the anti-vitamin C substance causes a fulminating scurvy condition to occur in the individual. ### Claim 6 (depends on 4) The method according to claim 4, wherein the anti-vitamin C substance is selected from the group consisting of a metal substance, a metalloid substance, an organic agent, an oxidizing agent, an infectious agent, and arsenic. ### Claim 7 (depends on 1) The method according to claim 1, wherein the plasma vitamin C level is reduced until the individual is scorbutic. ### Claim 8 (depends on 1) The method according to claim 1, wherein said drug is an agent for altering a level of cholesterol present in lipid rafts on a cell membrane in a plurality of diseased cells within said individual. ### Claim 9 (depends on 1) The method according to claim 1, wherein said drug is comprised of a clathrate forming substance. ### Claim 10 (depends on 9) The method according to claim 9, wherein the clathrate-forming substance is an anesthetic agent. ### Claim 11 A method for improving the removal of toxic fat deposits from the body of an individual for the purpose of preventing and treating disease, the method comprising the steps of: a) determining the individual's plasma vitamin C level; and b) altering the individual's diet in order to reduce the individual's plasma vitamin C level from a first level to a second level that is lower than the first level such that pathological modification of lipid rafts of said individual occurs; c) administering a treatment regimen selected from the group consisting of: administering a drug for the treatment of a diseased state to said individual, the drug selected from the group consisting of: a clathrate forming substance and an agent for altering a level of cholesterol present in lipid rafts on a cell membrane in a plurality of diseased cells within said individual; and administering a microbe for the treatment of a diseased state to said individual, the microbe. ### Claim 12 (depends on 11) The method according to claim 11 wherein the plasma vitamin C level is maintained at the second level for at least one month. ### Claim 13 (depends on 11) The method according to claim 11 further comprising the step of administering an anti-vitamin C substance to reduce the plasma vitamin C level from the second level to a third level that is lower than the first or second levels, the anti-vitamin C substance is selected from the group consisting of a metal substance, a metalloid substance, an organic agent, an oxidizing agent, an infectious agent, and arsenic. ### Claim 14 (depends on 11) The method according to claim 11, wherein the plasma vitamin C level is reduced until the individual becomes scorbutic. ### Claim 15 (depends on 11) The method according to claim 11 further comprising the step of administering a microbe to the individual. ### Claim 16 A method for the treatment of a pathogenic new growth in a patient, said method comprising the step of lowering a concentration of ascorbic acid or an oxidized or reduced derivative thereof in said pathogenic new growth for reducing the size thereof by scurvy induced phagocytosis. ### Claim 17 (depends on 16) A method according to claim 16 further comprising the step of administering an anti-vitamin C agent to the patient for lowering a concentration of ascorbic acid or an oxidized or reduced derivative thereof in said pathogenic new growth. ### Claim 18 (depends on 16) A method according to claim 16 further comprising the step of administering a clathrate forming substance in the form of an anesthetic agent. ### Claim 19 (depends on 18) A method according to claim 18, wherein said anesthetic agent is an ether compound. ### Claim 20 (depends on 16) A method according to claim 16, wherein said pathogenic new growth is selected from the group consisting of: cancerous lesions, tuberculosis lesions, lupus lesions and those lesions associated with insanity.